Journal of Vaccines & Vaccination

Plant virus expression vectors for biopharmaceutical production

7^th Middle East - Global Summit and Expo on Vaccines & Vaccination

September 28-29, 2015 Dubai, UAE

Kathleen Hefferon

Cornell University, USA

Posters-Accepted Abstracts: J Vaccines Vaccin

Abstract:

Plant made biologics have elicited much attention over recent years for their potential in assisting those in developing countries who have poor access to modern medicine. Additional applications such as the stockpiling of vaccines against pandemic infectious diseases or potential biological warfare agents are also under investigation. Plant virus expression vectors represent a technology that enables high levels of pharmaceutical proteins to be produced in a very short period of time. Recent advances in research and development have brought about the generation of superior virus expression systems which can be readily delivered to the host plant in a manner that is both efficient and cost effective. The following presentation describes recent innovations in plant virus expression systems and their uses for producing biologics from plants.

Biography :

Kathleen Hefferon has received her PhD from the Department of Medical Biophysics, University of Toronto and continued her Post-doctoral studies at Cornell University. He has worked on Faculty at the Division of Nutritional Sciences at Cornell and has written two books on biopharmaceuticals in plants. She teaches and conducts research at both the University of Toronto and Cornell University. She has 4 patents, edited 6 books and has multiple research publications.

Email: kathleen.hefferon@alumni.utoronto.ca